Business
GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
CHICAGO, August 28, 2025--Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, responsible for an estimated 20.5 million deaths globally.i
About this update from Ge Healthcare Technologies Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/0a61e271b0be9352d3b11599761dc84f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ooVKjCgpljDRmFl1Bxjjng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0a61e271b0be9352d3b11599761dc84f","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4oreSONGZm.un5jJBzzOeg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/0a61e271b0be9352d3b11599761dc84f","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Solutions including ViewPoint EchoPilot™, CardIQ Suite™ and Revolution™ Vibe have been newly granted CE mark and aim to streamline cardiac workflows and improve diagnostic confidence across the care continuum","length":208,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":208,"olType":false},{"type":"text","content":"CHICAGO, August 28, 2025--(BUSINESS WIRE)--Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, responsible for an estimated 20.5 million deaths globally.i","length":449,"tagName":"p"},{"type":"text","content":""Cardiovascular disease continues to place an immense and growing burden on health systems, clinicians, and patients worldwide," said Phil Rackliffe, President and CEO, Advanced Visualization Solutions at GE HealthCare. "At ESC, we’re demonstrating our commitment to empower care teams with innovations that help them meet these challenges head-on, using intelligent, connected tools designed to simplify workflows, accelerate diagnoses, and set a new standard in cardiac imaging – with the goal of ultimately improving outcomes for patients at every stage of their cardiac journey."","length":603,"tagName":"p"},{"type":"text","content":"GE HealthCare’s cardiology care pathway offering - spanning screening, diagnosis, int...